OpenVSafe by OpenVAERS
Search V-safe

C9S-50629-48909

3 vaccinations 7 coded responses 32 check-ins 7 free-text entries 1 call case
Sex
Female
Age at first dose
46-50
ZIP prefix
902 / CA
Registered
2020-12-23
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-22
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-23
    Registered in v-safe
  3. 2020-12-23
    Survey response — days 1–6 daily, dose 1
    MedDRA: Cold sweat, Hyperhidrosis — Feeling: Good · Site: Pain
    Free text: sweaty/clammy palms of hands and soles of feet, but not feeling warm overall
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2020-12-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  5. 2020-12-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2020-12-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2020-12-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2020-12-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2020-12-29
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-05
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-01-12
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-01-14
    Dose 2 — Pfizer-BioNTech
  13. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness, Diarrhea
    Adult check-in
  14. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-01-16
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  16. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Adult check-in
  17. 2021-01-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Itching · Joint pains, Fatigue or tiredness
    Adult check-in
  18. 2021-01-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Joint pains, Fatigue or tiredness
    Adult check-in
  19. 2021-01-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tiredness
    Adult check-in
  20. 2021-01-21
    Health check-in — day 7, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  21. 2021-01-28
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-04
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-11
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-02-20
    Survey response — day 35, dose 2
    MedDRA: Dizziness, Hypotension — Feeling: Fair
    Free text: hypotension, dizzy, lightheaded (have not called MD yet but will if this persists)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-02-27
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-04-15
    Survey response — 3 months, dose 2
    MedDRA: Diarrhoea — Feeling: Good · Be unable to do your normal daily activities
    Free text: diarrhea
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-07-15
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-12-02
    Dose 3 — Pfizer-BioNTech
  29. 2021-12-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  30. 2021-12-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  31. 2021-12-08
    Survey response — days 1–6 daily, dose 3
    MedDRA: Eye irritation, Eye pain — Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Eye irritation/pain started Friday and has gotten progressively worse
    MedDRA releases: 2024-11 · check-in free text available
  32. 2021-12-09
    Health check-in — day 7, dose 3
    Feeling: Fair · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Adult check-in
  33. 2021-12-16
    Survey response — day 14, dose 3
    MedDRA: Eye pain, Rash — Feeling: Fair
    Free text: Continued eye pain and rash.
    MedDRA releases: 2024-11 · check-in free text available
  34. 2021-12-23
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  35. 2021-12-30
    Survey response — day 28, dose 3
    MedDRA: Rash — Feeling: Good
    Free text: Most of the rash gone, but this week it suddenly appeared on the left side of my forehead.
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-01-06
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  37. 2022-01-13
    Survey response — day 42, dose 3
    MedDRA: Fatigue, Headache, Heart rate increased, Rash — Feeling: Fair · Be unable to do your normal daily activities
    Free text: rash comes and goes (limited now to left side of forehead and both forearms), headaches, fatigue, increased heart rate during sleep (tracked by my watch)
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-22Pfizer-BioNTech
22021-01-14Pfizer-BioNTech
32021-12-02Pfizer-BioNTech No

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-23

Systemic reaction (other): sweaty/clammy palms of hands and soles of feet, but not feeling warm overall

Release 4 — day 35, dose 2

2021-02-20

Symptoms: hypotension, dizzy, lightheaded (have not called MD yet but will if this persists)

Release 7 — 3 months, dose 2

2021-04-15

Symptoms: diarrhea

Release 10 — days 1–6 daily, dose 3

2021-12-08

Systemic reaction (other): Eye irritation/pain started Friday and has gotten progressively worse

Release 10 — day 14, dose 3

2021-12-16

Symptoms: Continued eye pain and rash.

Release 10 — day 28, dose 3

2021-12-30

Symptoms: Most of the rash gone, but this week it suddenly appeared on the left side of my forehead.

Release 10 — day 42, dose 3

2022-01-13

Symptoms: rash comes and goes (limited now to left side of forehead and both forearms), headaches, fatigue, increased heart rate during sleep (tracked by my watch)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDiarrhoea ✓ ✓ ✓
SDDizziness ✓ ✓ ✓
SDEye pain · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDHeart rate increased · · ✓
SDHypotension ✓ ✓ ✓
SDRash · · ✓
SROCold sweat ✓ ✓ ✓
SROEye irritation · · ✓
SROEye pain · · ✓
SROHyperhidrosis ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release